These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28565816)

  • 41. Erratum: MicroRNA-183 suppresses the vitality, invasion and migration of human osteosarcoma cells by targeting metastasis-associated protein 1.
    Sun X; Xu Y; Zhang S; Li X; Wang Y; Zhang Y; Zhao X; Li Y; Wang Y
    Exp Ther Med; 2022 Jan; 23(1):25. PubMed ID: 34815777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-365 Targets Multiple Oncogenes to Inhibit Proliferation, Invasion, and Self-Renewal of Aggressive Endometrial Cancer Cells [Retraction].
    Cancer Manag Res; 2021; 13():8555-8556. PubMed ID: 34849022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA-200a functions as a tumor suppressor by targeting FOXA1 in glioma.
    Chen X; Liu K; Yang P; Kuang W; Huang H; Tu E; Li B; Zhu Y; Zhou B; Yan L
    Exp Ther Med; 2019 Jan; 17(1):221-229. PubMed ID: 30651786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
    Liu CZ; Liu W; Zheng Y; Su JM; Li JJ; Yu L; He XD; Chen SS
    Chin Med Sci J; 2012 Jun; 27(2):65-72. PubMed ID: 22770403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Retracted] Suppressive effect of microRNA‑138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1.
    Yuan Z; Mo H; Mo L; He J; Wu Z; Lin X
    Exp Ther Med; 2023 Feb; 25(2):95. PubMed ID: 36761003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.
    Sritananuwat P; Sueangoen N; Thummarati P; Islam K; Suthiphongchai T
    Cancer Cell Int; 2017; 17():85. PubMed ID: 28959141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.
    Wang Z; He R; Xia H; Wei Y; Wu S
    Exp Ther Med; 2021 Sep; 22(3):978. PubMed ID: 34349849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Retracted] MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L.
    Pan Y; Jin K; Xie X; Wang K; Zhang H
    Exp Ther Med; 2022 Oct; 24(4):620. PubMed ID: 36160892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Retracted] MicroRNA‑877 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting IGF‑1R.
    Zhou G; Xie J; Gao Z; Yao W
    Exp Ther Med; 2022 Nov; 24(5):651. PubMed ID: 36168414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MicroRNA-30a inhibits proliferation of hepatocellular carcinoma cells via targeted regulation of forkhead-box protein A1].
    Li Y; Fu L; Fu XY; Li RH; Peng SF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):706-711. PubMed ID: 29108194
    [No Abstract]   [Full Text] [Related]  

  • 55. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
    Zhu Z; Chen W; Yin X; Lai J; Wang Q; Liang L; Wang W; Wang A; Zheng C
    Dig Dis Sci; 2016 Jul; 61(7):1950-60. PubMed ID: 26971088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
    Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
    Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulatory role of garlicin in migration and invasion of intrahepatic cholangiocarcinoma via PI3K/AKT pathway.
    Xie K; Nian J; Zhu X; Geng X; Liu F
    Int J Clin Exp Pathol; 2015; 8(11):14028-33. PubMed ID: 26823715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum: MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis.
    Hu LK; Chen JQ; Zheng H; Tao YP; Yang Y; Xu XF
    Exp Ther Med; 2022 Jul; 24(1):463. PubMed ID: 35747148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.